The global angiography equipment market is valued at USD 10.46 billion in 2023 and is projected to grow at a CAGR of 6.1% during the forecast period 2024-2032, reaching USD 17.82 billion by 2032. The market growth is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs), growing adoption of minimally invasive procedures, and rapid advancements in angiography technology.
Cardiovascular diseases continue to be a major global health concern, causing 20% of all deaths in 2023, according to the CDC. Rising risk factors such as hypertension, diabetes, sedentary lifestyles, and obesity further contribute to the growing demand for advanced diagnostic and therapeutic procedures, including coronary angiography and endovascular interventions.
Technological Advancements- Continuous innovations in angiography systems have improved diagnostic precision, reduced radiation exposure, and enhanced patient safety. Technologies such as AI-powered diagnostics, 3D imaging, and robotic-assisted interventions are redefining imaging standards. For instance, Shimadzu Corporation launched SMART Voice in 2024 to optimize workflow efficiency for catheter-based angiography procedures.
Demographic Trends- The aging global population is significantly contributing to market demand. By 2024, 10% of the world's population is aged 65 or older, resulting in a higher incidence of chronic conditions such as coronary artery disease (CAD). This demographic shift is fostering the demand for accurate diagnostic and therapeutic equipment across healthcare facilities.
Regional Highlights
- North America leads the global market with a 33.0% revenue share in 2024, driven by advanced healthcare infrastructure, strong R&D activities, and the early adoption of innovative technologies.
- Asia Pacific is anticipated to grow at the fastest CAGR of 6.4%, owing to increasing healthcare expenditure, government initiatives, and rising cases of CVDs in countries like India, China, and Japan.
- Europe maintains a significant market share due to the well-established healthcare systems in Germany, France, and the UK, alongside continued investments in healthcare technology.
Major Market Players Included in This Report
- Medtronic plc
- Boston Scientific Corporation
- Abbott
- Angiodynamics, Inc.
- Microport Scientific Corporation
- B. Braun SE
- Koninklijke Philips N.V.
- GE Healthcare
- Siemens Healthineers AG
- Shimadzu Corporation
- Terumo Corporation
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- Cardinal Health
- NIDEK CO., LTD.
The Detailed Segments and Sub-Segments of the Market Are Explained Below:
By Product:
- Angiography Systems
- Catheters
- Guidewires
- Balloons
- Contrast Media
- Vascular Closure Devices
- Accessories
By Technology:
- X-Ray
- MRA (Magnetic Resonance Angiography)
- CT (Computed Tomography)
By Procedure:
- Coronary
- Endovascular
- Neurovascular
By Application:
By End-Use:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Years Considered for the Study
- Historical Year: 2022
- Base Year: 2023
- Forecast Period: 2024-2032
Key Takeaways:
- Market Estimates and forecasts for 10 years from 2022 to 2032.
- Annualized revenues and regional-level analysis for each market segment.
- Detailed analysis of the geographical landscape, with country-level insights for major regions.
- Competitive landscape with information on key market players and their strategies.
- Analysis of key business strategies and recommendations on future market approaches.
- Examination of technological innovations, focusing on AI integration and low-dose imaging technologies.
- Demand-side and supply-side analysis of the market with a focus on emerging trends.
- Key factors driving North America dominance and Asia Pacific's high growth rate.